Astrazeneca Joins Accumulus Synergy as a Sponsor to Accelerate the Delivery of Medicines to Patients
Accumulus Synergy, a nonprofit organization working to develop an information and data exchange platform aimed at transforming how drug innovators and health authorities worldwide interact, today announced AstraZeneca (LSE/STO/Nasdaq: AZN) has joined Accumulus Synergy as a sponsor company.
Continue Reading